FGL 05 Pill - gray & yellow capsule/oblong
Pill with imprint FGL 05 is Gray & Yellow, Capsule/Oblong and has been identified as Fingolimod 0.5 mg. It is supplied by Aurobindo Pharma Limited.
Fingolimod is used in the treatment of Multiple Sclerosis and belongs to the drug class selective immunosuppressants. Risk cannot be ruled out during pregnancy. Fingolimod 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for FGL 05
Fingolimod
- Imprint
- FGL 05
- Strength
- 0.5 mg
- Color
- Gray & Yellow (bright yellow/grey)
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 65862-0952
See also:
Copaxone
Copaxone is used to treat relapsing forms of multiple sclerosis (MS) in adults (including ...
Tecfidera
Tecfidera (dimethyl fumarate) is used to treat relapsing forms of multiple sclerosis. Learn about ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Aubagio
Aubagio (teriflunomide) is used to reduce flare-ups in people with relapsing multiple sclerosis ...
Avonex
Avonex is an interferon used to treat relapsing multiple sclerosis. It is given by injection into a ...
Gilenya
Gilenya (fingolimod) is used to treat relapsing forms of multiple sclerosis. Includes Gilenya side ...
Tysabri
Tysabri is used to treat multiple sclerosis and Crohn's disease. Learn about side effects ...
Ampyra
Ampyra (dalfampridine) is used to improve walking in patients with multiple sclerosis. Includes ...
More about fingolimod
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (99)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.